Adult-type diffuse gliomas |
Astrocytoma, IDH-mutant |
IDH1, IDH2, ATRX, TP53, CDKN2A/B |
Oligodendroglioma, IDH-mutant, and 1p/19q-codeleted |
IDH1, IDH2, 1p/19q, TERT promoter, CIC, FUBP1, NOTCH1 |
Glioblastoma, IDH-wildtype |
IDH-wildtype, TERT promoter, chromosomes 7/10, EGFR |
Pediatric type diffuse low-grade gliomas |
Diffuse astrocytoma, MYB- or MYBL1-altered |
MYB, MYBL1 |
Angiocentric glioma |
MYB |
Polymorphous low-grade neuroepithelial tumor of the young |
BRAF, FGFR family |
Diffuse low-grade glioma, MAPK pathway-altered |
FGFR1, BRAF |
Pediatric type diffuse low-grade gliomas |
Diffuse midline glioma, H3 K27-altered |
H3 K27, TP53, ACVR1, PDGFRA, EGFR, EZHIP |
Diffuse hemispheric glioma, H3 G34-mutant |
H3 G34, TP53, ATRX |
Diffuse pediatric-type high-grade glioma, H3-wildtype, and IDH-wildtype |
IDH-wildtype, H3-wildtype, PDGFRA, MYCN, EGFR (methylome) |
Infant-type hemispheric glioma |
NTRK family, ALK, ROS, MET |
Circumscribed astrocytic gliomas |
Pilocytic astrocytoma |
KIAA1549-BRAF, BRAF, NF1 |
High-grade astrocytoma with piloid features |
BRAF, NF1, ATRX, CDKN2A/B (methylome) |
Pleomorphic xanthoastrocytoma |
BRAF, CDKN2A/B |
Subependymal giant cell astrocytoma |
TSC1, TSC2 |
Chordoid glioma |
PRKCA |
Astroblastoma, MN1-altered |
MN1 |